Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine

Pentostatin

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

Is there a shortage of Pentostatin?
The FDA drug shortage list shows “Current shortage” for a product of this medicine (updated October 21, 2026). Ask your pharmacist about alternatives.
Has Pentostatin been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Pentostatin?
1 company lists prescription products of Pentostatin in the FDA NDC Directory, including Hospira, Inc..

What Pentostatin is used for

We did not find an “Indications and Usage” section in the FDA labels for this medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Forms and how it is given

Dosage formsInjection, powder, lyophilized, for solution
RouteIntravenous
Prescription products1 in the FDA NDC Directory
Brand namesNipent

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA020122
NIPENT
Hospira IncOctober 11, 1991 11, latest November 3, 2025
2025: Labeling · 2019: Labeling · 2015: Manufacturing (CMC)

Shortage status

Current shortage · updated October 21, 2026 · first posted August 27, 2026

ProductNipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01)
AvailabilityUnavailable
Reason givenOther
CompanyHospira, Inc., a Pfizer Company

Ask your pharmacist whether your product is affected and what the options are.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

FDA labels (SPL)0
FDA applicationsNDA020122
Active ingredients (FDA)PENTOSTATIN

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  4. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers